Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever
Study the Clinical and Laboratory Characteristics and the Outcome of Sickle Cell Anemia Patients Admitted to the Pediatric Ward Because of Fever as the Presenting Symptom
Lead Sponsor: HaEmek Medical Center, Israel
|Source||HaEmek Medical Center, Israel|
This study will summarized the clinical and laboratory data and the outcome of all the patients suffering from Sickle Cell Anemia (Including Sickle cell thalassemia) admitted to the pediatric ward.
The actual protocol for SCA patients admitted with fever is to obtain blood cultures and start empiric antibiotic treatment.
The study cohort included 60 SCA patients actually treated in the Pediatric Hematology Unit.
|Start Date||May 2008|
|Completion Date||November 2008|
Intervention Type: Other
Intervention Name: Observational
Description: Summary of clinical and laboratory data
Sampling Method: Probability Sample
Inclusion Criteria: All patients admitted with fever as the only presenting symptom. Exclusion Criteria: Patients admitted with another causes related or unrelated to sickle cell disease and have also fever.
Inclusion Criteria: All patients admitted with fever as the only presenting symptom.
Exclusion Criteria: Patients admitted with another causes related or unrelated to sickle cell disease and have also fever.
Minimum Age: N/A
Maximum Age: N/A
Healthy Volunteers: No
Type: Principal Investigator
Investigator Affiliation: HaEmek Medical Center, Israel
Investigator Full Name: Dr Koren Ariel
Investigator Title: Head of Pediatric Hematology Unit and Pediatric Dpt B
|Has Expanded Access||No|
Description: Sickle cell anemia
Description: Sickle cell thalassemia
|Study Design Info||
Time Perspective: Retrospective